Medical Device Classification: FDA Class I-III and EU MDR Rules Explained

Classification is the first regulatory decision for any medical device, and it drives almost everything that follows: which submission route you use, how much clinical evidence you need, whether a notified body is involved, and how much your compliance programme will cost. Getting it wrong early means wasted effort or, worse, a surprise reclassification late in development. This guide explains how FDA and the EU MDR classify devices, how the two systems differ, and a practical method for documenting your classification decision.

Why classification comes first

Both regulators classify devices by risk, but they use different structures. In the United States, a device’s class and product code tell you whether you need a 510(k), De Novo or PMA. In the EU, the class tells you which conformity assessment route applies and whether a notified body must review your technical documentation. Because the same device can land in different classes in the two regions, classification should be analysed separately for each market, then compared when you set your regulatory strategy.

First: is it a medical device at all?

Before classifying, confirm the product meets the definition. In the US that is the definition in section 201(h) of the FD&C Act; in the EU it is MDR Article 2(1). Intended purpose decides the question: what the manufacturer claims in labeling, instructions, marketing and the clinical evidence. Software deserves particular care; our article Is my software a medical device? walks through that analysis.

FDA classification: Class I, II and III

Class	Risk level	General controls?	Typical premarket route
Class I	Low	Yes	Mostly exempt from 510(k); some exempt from design controls
Class II	Moderate	Yes, plus special controls	510(k) in most cases, some exempt; De Novo if no predicate
Class III	High, life-supporting or implanted	Yes, plus premarket approval	PMA

FDA’s classification is regulation-based. The Code of Federal Regulations (21 CFR Parts 862 to 892) lists device types by medical specialty, each with a classification and, where applicable, special controls. Practical steps to find your class:

1. Search FDA’s Product Classification database and the Device Classification regulations for the device type that matches your intended use and technology.
2. Identify the product code and regulation number, and check whether the device is exempt from 510(k) or from parts of the quality system.
3. Review similar cleared devices to see how they were classified and which special controls apply.
4. If the device is new and low-to-moderate risk with no predicate, consider the De Novo pathway.
5. If the classification is unclear, FDA offers a 513(g) request for information, and the Q-Submission program lets you discuss classification and pathway in a Pre-Submission meeting.

Class determines the pathway in broad terms: see the 510(k) submission process for the most common route and US FDA medical device regulations for the overall picture.

EU MDR classification: Classes I, IIa, IIb and III

The MDR classifies devices using 22 rules in Annex VIII, based on intended purpose and technical characteristics. The classes are I, IIa, IIb and III, with sub-classes for Class I devices:

• Class I: lowest risk. The manufacturer can self-certify unless the device is sterile (Is), has a measuring function (Im) or is a reusable surgical instrument (Ir), in which case a notified body reviews the relevant aspects.
• Class IIa and IIb: medium risk, requiring notified body conformity assessment.
• Class III: highest risk, including many implantables and devices that act on the heart or central circulatory system, with the most demanding review.

How the rules work

The rules are grouped by device type: non-invasive devices (Rules 1 to 4), invasive devices (Rules 5 to 8), active devices (Rules 9 to 13) and special rules (Rules 14 to 22), covering contraception, disinfecting and cleaning products, devices made of substances absorbed by the body and closed-loop systems. Several features push a device into a higher class: duration of contact, invasiveness, whether it is implantable, whether it delivers energy or substances, and whether it affects vital organs.

Two rules cause frequent surprises:

• Rule 11 (software): software intended to provide information used to make decisions with diagnosis or therapeutic purposes is Class IIa at minimum, rising to IIb or III depending on the possible impact of those decisions. Many software products that were Class I under the old directives are now higher. MDCG guidance on software qualification and classification explains the interpretation.
• Rule 21 (substance-based devices): devices composed of substances introduced into the body or applied to the skin can be classified up to Class III depending on how they are absorbed and where they act.

When several rules apply, the highest class wins (Annex VIII, implementing rule 3.5). Classification is by intended purpose, so a change in claims can change the class.

For the full EU picture, see EU MDR and IVDR explained.

FDA and EU MDR side by side

Aspect	FDA	EU MDR
Number of classes	3 (I, II, III)	4 (I, IIa, IIb, III) plus Class I sub-classes
Basis	Device type in regulation and product code	22 rules applied to intended purpose and characteristics
Who checks	FDA reviews premarket submissions (many Class I exempt)	Notified body for everything above basic Class I
Software	Classified by function and risk; enforcement discretion for some low-risk software	Rule 11 often raises software to IIa or higher
Dispute route	513(g), Pre-Submission	Notified body opinion, competent authority decision

Do not assume equivalence between the classes. A US Class II device may be EU Class IIb, and a US Class I exempt device may need a notified body under the MDR.

A practical method for documenting classification

1. Write a precise intended purpose statement: indication, patient population, user, environment, duration of use.
2. Describe the device characteristics that matter for classification: invasive or not, active or not, duration of contact, anatomical site, energy, software function.
3. Walk through each applicable rule or regulation and record the outcome and the reasoning, including rules you considered and rejected.
4. Record the resulting class in each target market, the conformity route or submission pathway and any exemptions.
5. Review the decision at every design change and whenever claims, labeling or technology change.

Keep the classification memo in the technical documentation and the design file. It is one of the first things a reviewer or auditor reads.

Common mistakes

• Using a competitor’s class as proof without checking intended purpose or technology.
• Classifying once and never revisiting after adding a claim or a software feature.
• Applying only the single most obvious MDR rule instead of working through all 22.
• Assuming a Class I US device is Class I in the EU.
• Ignoring accessories, which are classified in their own right under the MDR.

Frequently asked questions

Can the same device have different classes in the US and EU?

Yes, and it is common. The two systems use different frameworks and definitions, so you must classify separately for each market and plan the submission accordingly.

What if my device fits more than one MDR rule?

The rule that results in the higher class applies. Document every rule you considered, not just the one that determined the outcome.

How do I get FDA’s view on classification before filing?

You can use a 513(g) request for information or a Pre-Submission under the Q-Submission program. Both give you FDA’s current thinking, though neither is a formal determination in the way a cleared or granted submission is.

Does classification change over time?

It can. Regulators revise classification regulations and guidance, and a change in your device or claims can alter the class. Review classification whenever the product or regulatory landscape changes.

Classification rules, guidance documents and databases are updated regularly. Confirm your device’s class against the current regulation, the regulator’s database and the latest guidance before making a submission decision.

Related reading

• US FDA medical device regulations: classification, pathways and QMSR.
• EU MDR and IVDR explained: roles, conformity assessment and CE marking.
• FDA vs EU MDR for the RAC exam: how the two systems compare.
• EU MDR and FDA interview case studies: pathway choice for software.

Talk to the AptSkill team

Want hands-on training in FDA and EU MDR regulatory affairs? Send us your role and goal.